4//SEC Filing
Singh Vanila 4
Accession 0001103021-21-000084
CIK 0001103021other
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:39 PM ET
Size
11.7 KB
Accession
0001103021-21-000084
Insider Transaction Report
Form 4
Singh Vanila
Director
Transactions
- Exercise/Conversion
Common Stock
2021-08-23+4,000→ 22,834 total - Award
Restricted Stock Units
2021-08-23+8,000→ 8,000 totalExercise: $0.00Exp: 2022-08-23→ Common Stock (8,000 underlying) - Exercise/Conversion
Restricted Stock Units
2021-08-23−4,000→ 4,000 totalExercise: $0.00Exp: 2022-08-23→ Common Stock (4,000 underlying) - Award
Stock Options (right to buy)
2021-08-23$3.76/sh+48,000$180,480→ 48,000 totalExercise: $3.76Exp: 2031-08-23→ Common Stock (48,000 underlying)
Footnotes (2)
- [F1]The restricted stock units ("RSUs") were issued to the Reporting Person on August 23, 2021 (the "Effective Date"), as compensation for service on the Company's board of directors. The RSUs vest as follows: (i) 4,000 RSUs vested in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, and (ii) 4,000 RSUs will vest upon the earlier of (i) the first anniversary of the Effective Date or (ii) the Company's 2022 Annual Meeting of Stockholders.
- [F2]The stock options ("options") were issued to the Reporting Person on the Effective Date, as compensation for service on the Issuer's board of directors. The options vest as follows: (i) 24,000 options vested in the first open window following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, and (ii) 24,000 options will vest upon the earlier of (i) the first anniversary of the Effective Date or (ii) the Company's 2022 Annual Meeting of Stockholders.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001795397
Filing Metadata
- Form type
- 4
- Filed
- Aug 24, 8:00 PM ET
- Accepted
- Aug 25, 4:39 PM ET
- Size
- 11.7 KB